Skip to main content

Roche’s new AAN 2020 data Event

Roche has hosted a live audio webcast and conference call on Tuesday, 28 April 2020.

Agenda
Agenda:
WelcomeKarl Mahler, Head of Investor Relations and Roche Group Planning
Risdiplam: FIREFISH part 2 efficacy and safety in infants with type 1 SMAProf. Laurent Servais, MDUK Oxford Neuromuscular Center, Department of Paediatrics, University of Oxford, UK
Risdiplam: Update on clinical development program
OCREVUS: Long-term data on key markers of disability progression in MS Shorter infusion (ENSEMBLE PLUS) data and regulatory updatePaulo Fontoura, M.D. Ph.D., Global Head Neuroscience and Rare Diseases Clinical Development
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Related links

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Roche’s Annual Report 2019

    Investors

    How medicines are making an impact in the lives of patients

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions